The 105-hospital chain’s shares traded between $1.79 and $1.90 on Aug. 27 after closing Aug. 26 at $1.86 per share. CHS’ share price fell 1.06 percent on Aug. 26 and was down 3.6 percent on Aug. 23.
In the last year, CHS shares have traded between $1.79 and $5.35.
CHS has been selling off hospitals in recent years to improve its financial position and reduce its heavy debt load. In late 2017, the company announced a plan to sell a group of hospitals with combined annual revenue of $2 billion. During 2018, the company completed 11 hospital divestitures and permanently closed three hospitals. As of Aug. 1, CHS had completed the divestiture of nine hospitals this year.
CHS carried $13.88 billion in long-term debt when it announced its divestiture plan at the end of 2017. Its long-term debt totaled $13.39 billion as of June 30.
More articles on healthcare finance:
Ohio hospital’s Medicare contract in jeopardy
10 hospitals seeking CFOs
Mayo Clinic’s operating income jumps 88% in Q2
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
